D.E. Shaw & Co’s Amryt Pharma AMYT Stock Holding History
Bought
Maintained
Sold
Other funds holding AMYT
ACM
D.E. Shaw & Co's AMYT Position: Q4 2022 in Review
D.E. Shaw & Co sold out of Amryt Pharma (AMYT) in Q4 2022, closing a stake of 22,428 shares — an estimated $155K sold.
D.E. Shaw & Co first reported a position in AMYT in Q2 2022 and held it in 2 quarters. The position peaked at $155K in Q3 2022. 58 funds tracked by Wall St. Rank hold AMYT as of Q4 2022.
- D.E. Shaw & Co reported no remaining Amryt Pharma position as of Q4 2022 after selling out during the quarter.
- D.E. Shaw & Co sold 22,428 Amryt Pharma shares in Q4 2022, an estimated $155K.
- D.E. Shaw & Co first reported a position in Amryt Pharma in Q2 2022 and held it in 2 quarters.
- D.E. Shaw & Co's Amryt Pharma position peaked at $155K in Q3 2022.
- 58 funds tracked by Wall St. Rank held Amryt Pharma as of Q4 2022.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.